ArticleFrontiers in pediatrics2025

Analysis of adverse reactions and cost-driving factors during the induction phase of pediatric acute lymphoblastic leukemia.

Zhonghao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.